Diverse HIV-1 genetic subtypes in UK

Population reach, feasibility and acceptability of digital therapeutics for smoking cessation among people living with HIV: Results of the Quitting Matters pilot trial.

Drug and alcohol dependence·2026

Involving youth with intellectual and/or developmental disabilities as collaborators in a comparative effectiveness trial: A community-engaged research approach.

Contemporary clinical trials communications·2024

Impurity characterization in diamond for quantum and electronic applications: advances with time-resolved cathodoluminescence.

Nanotechnology·2024

Photon correlations in the collective emission of hybrid gold-(CdSe/CdS/CdZnS) nanocrystal supraparticles.

Nanotechnology·2024

CTP-based estimated ischemic core: A comparative multicenter study between Olea and RAPID software.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2023

Fluorescence decay enhancement and FRET inhibition in self-assembled hybrid gold CdSe/CdS/CdZnS colloidal nanocrystal supraparticles.

Optics express·2023

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Psoriasis.

Lancet (London, England)·2026

Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial.

Lancet (London, England)·2026

Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study.

Lancet (London, England)·2026

Oral step-down, optimal drug, and total duration of antibiotic treatment in African children hospitalised with severe community-acquired pneumonia (PediCAP): a factorial randomised controlled trial.

Lancet (London, England)·2026

YAP/TEAD complex restricts H3K27ac deposition to suppress testosterone synthesis in adult Leydig cells.

Histochemistry and cell biology·2026

Extensive binding of poorly characterized human transcription factors to genomic dark matter.

Nature communications·2026

The Evolutionarily-conserved C-terminal tail of the Dib1 Protein is Required for Spliceosome Efficacy and Dib1 Protein Stability.

The Journal of biological chemistry·2026

Genome and global context of a blaNDM-5-positive Salmonella enterica ST34 with deletion of the glucitol phosphotransferase system.

Journal of global antimicrobial resistance·2026

α-Satellite RNA maintains centromeric cohesion through R-loops.

Molecular cell·2026

Stepwise DNA-unwinding gates TnpB genome-editing activity.

Molecular cell·2026

Related Experiment Videos

Diverse HIV-1 genetic subtypes in UK

Related Concept Videos

Population reach, feasibility and acceptability of digital therapeutics for smoking cessation among people living with HIV: Results of the Quitting Matters pilot trial.

Involving youth with intellectual and/or developmental disabilities as collaborators in a comparative effectiveness trial: A community-engaged research approach.

Impurity characterization in diamond for quantum and electronic applications: advances with time-resolved cathodoluminescence.

Photon correlations in the collective emission of hybrid gold-(CdSe/CdS/CdZnS) nanocrystal supraparticles.

CTP-based estimated ischemic core: A comparative multicenter study between Olea and RAPID software.

Fluorescence decay enhancement and FRET inhibition in self-assembled hybrid gold CdSe/CdS/CdZnS colloidal nanocrystal supraparticles.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Psoriasis.

Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial.

Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study.

Oral step-down, optimal drug, and total duration of antibiotic treatment in African children hospitalised with severe community-acquired pneumonia (PediCAP): a factorial randomised controlled trial.

YAP/TEAD complex restricts H3K27ac deposition to suppress testosterone synthesis in adult Leydig cells.

Extensive binding of poorly characterized human transcription factors to genomic dark matter.

The Evolutionarily-conserved C-terminal tail of the Dib1 Protein is Required for Spliceosome Efficacy and Dib1 Protein Stability.

Genome and global context of a blaNDM-5-positive Salmonella enterica ST34 with deletion of the glucitol phosphotransferase system.

α-Satellite RNA maintains centromeric cohesion through R-loops.

Stepwise DNA-unwinding gates TnpB genome-editing activity.

Related Experiment Videos

Diverse HIV-1 genetic subtypes in UK

Related Concept Videos

Related Articles